Inhibition of cyclooxygenase-independent platelet aggregation by low vitamin E concentration

      This paper is only available as a PDF. To read, Please Download here.


      Platelet aggregation induced by threshold concentrations of agonists such as collagen, PAF or epinephrine was inhibited in vitro by 100 μM aspirin but was restored by stimulating platelets with high concentrations of collagen, PAF or by a combination of epinephrine and PAF. Incubating aspirin-treated platelets with 50-100 μM vitamin E or vitamin E acetate inhibited platelet aggregation by high concentrations of collagen and PAF and by the combination of epinephrine and PAF; platelet thromboxane A2 formation was less than 10% in samples incubated with 100 μM aspirin. Apyrase, added to aspirin-treated platelet, did not influence platelet aggregation induced by epinephrine and PAF. The present study suggests that concentrations of vitamin E as low as 50-100 μM inhibit cyclooxygenase-independent platelet aggregation when combined with an inhibitor of the arachidonate pathway.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Steiner M.
        • Mower R.
        Mechanism of action of vitamin E on platelet function.
        Ann. N.Y. Acad. Sci. 1982; 393: 289
        • Cordova C.
        • Violi F.
        • Ghiselli A.
        • Alessandri C.
        • Frattaroli S.
        In vitro effect of vitamin E and butylated hydroxytoluene on plasma malondialdehyde-like material.
        Thromb. Haemost. 1986; 55: 296
        • Cordova C.
        • Musca A.
        • Violi F.
        • Alessandri C.
        • Ghiselli A.
        • Iuliano L.
        • Balsano F.
        Influence of vitamin E on plasma malondialdehyde-like material in man.
        Thromb. Haemostas. 1984; 51: 347
        • Pritchard K.A.
        • Greco N.J.
        • Panganamala R.V.
        Effect of dietary vitamin E on the production of platelet 12-hydroxyeicosatetraenoic acid (12-HETE).
        Thromb. Haemost. 1986; 55: 6
        • Steiner M.
        • Anastasi J.
        Vitamin E. An inhibitor of the platelet release reaction.
        J. Clin. Invest. 1976; 57: 732
        • Vatassery G.T.
        • Krerowsky A.M.
        • Eckefeldt J.H.
        Vitamin E in plasma and platelets of human diabetic patients and control subjects.
        Am. J. Clin. Invest. 1983; 37: 1020
        • Patrignani P.
        • Filabozzi P.
        • Patrono C.
        Selective cumulative inhibition of platelet thromboxane production by low dose of aspirin in healthy subjects.
        J. Clin. Invest. 1982; 69: 1366
        • Violi F.
        • Ghiselli A.
        • Alessandri C.
        • Frattaroli S.
        • Iuliano L.
        • Balsano F.
        Activation of platelets by red blood cells in vitro.
        N. Engl. J. Med. 1985; 313: 1091
        • Born G.V.R.
        Aggregation of blood platelets by adenosine diphosphate and its reversal.
        Nature. 1962; 194: 927
        • Jandrot-Perrus M.
        • Guillin M.C.
        • Nurden A.T.
        Human gamma-thrombin: lack of correlation between a platelet functional response and glycoprotein V hydrolysis.
        Thromb. Haemost. 1987; 58: 915
        • Hatam L.J.
        • Kayden H.J.
        A high-performance liquid chromatographic method for the determination of tocopherol in plasma and cellular elements of the blood.
        J. Lipid Res. 1979; 20: 639
        • Clevidence B.A.
        • Lehmann J.
        Alpha- and gammatocopherol levels in lipoproteins fractioned by affinity chromatography.
        Lipids. 1989; 24: 137
        • Emms H.
        • Lewis G.P.
        The roles of prostaglandin endoperoxides, thromboxane A2 and adenosine diphosphate in collagen-induced aggregation in man and the rat.
        Br. J. Pharmacol. 1986; 87: 109
        • Chesney C.M.
        • Pifer D.D.
        • Byers L.W.
        • Muirhead E.E.
        Effect of platelet-activating factor (PAF) on thromboxane production.
        Blood. 1982; 59: 582
        • Violi F.
        • Pratico'D Ghiselli A.
        • Alessandri C.
        • Cordova C.
        Human platelet aggregation by PAF and thromboxane production.
        Thromb. Res. 1987; 48: 265
        • Huang E.M.
        • Detwiler T.C.
        Characteristics of the synergestic actions of platelet agonists.
        Blood. 1981; 57: 685
        • Keraly C.L.
        • Kinlough-Rathbone R.L.
        • Packham M.A.
        • Suzuki H.
        • Mustard J.F.
        Conditions affecting the responses of human platelets to epinephrine.
        Thromb. Haemost. 1988; 60: 207
        • Figures W.R.
        • Scearce L.M.
        • Wachtfogel Y.
        • Chen J.
        • Colman R.F.
        • Colman R.W.
        Platelet ADP receptor and α-2-adreno receptor interaction. Evidence for an ADP requirement for epinephrine induced platelet activation and an influence of epinephrine on ADP binding.
        J. Biol. Chem. 1986; 261: 5981
        • Cerletti C.
        • Carriero M.R.
        • De Gaetano G.
        Platelet aggregation response to single or paired aggregating stimuli after low-dose aspirin.
        N. Engl. J. Med. 1986; 314: 316